JPMorgan is sticking with Eli Lilly (LLY) as its top biopharma pick for 2025, while also highlighting Gilead Sciences (GILD) ...

In 2025, church members are visible across all aspects of sports — as athletes, coaches, owners and executives.

Veradigm will add four new directors to its board in an agreement with investor Kent Lake Capital, the healthcare technology company said on Thursday just weeks after concluding a strategic review.